Analyst Recommendations

CFRA analyst issues BUY recommendation for TSLA on March 16, 2024 05:00AM ET. The previous analyst recommendation was Buy.TSLA was trading at $163.57 at issue of the analyst...

March 18, 2024   TSLA 5.33%

Piper Sandler analyst issues OVERWEIGHT recommendation for ADBE on March 15, 2024 07:54AM ET. The previous analyst recommendation was Overweight.ADBE was trading at $570.45 at issue of the...

March 15, 2024   ADBE 0.67%

Tigress Financial analyst issues BUY recommendation for COST on March 15, 2024 07:54AM ET. The previous analyst recommendation was Buy.COST was trading at $731.95 at issue of the...

March 15, 2024   COST 1.12%

UBS analyst issues NEUTRAL recommendation for TSLA on March 14, 2024 08:33AM ET. The previous analyst recommendation was Neutral.TSLA was trading at $167.24 at issue of the analyst...

March 14, 2024   TSLA 5.33%

Wells Fargo analyst issues UNDERWEIGHT recommendation for TSLA on March 14, 2024 02:18AM ET. The previous analyst recommendation was Equal-Weight.TSLA was trading at $169.48 at issue of the...

March 14, 2024   TSLA 5.33%

Citigroup analyst issues BUY recommendation for AVGO on March 13, 2024 01:33PM ET. The previous analyst recommendation was Buy.AVGO was trading at $1266.87 at issue of the analyst...

March 13, 2024   AVGO 2.12%

Benchmark analyst issues BUY recommendation for NVDA on March 13, 2024 08:51AM ET. The previous analyst recommendation was Buy.NVDA was trading at $919.13 at issue of the analyst...

March 13, 2024   NVDA 0.25%

Wedbush analyst issues OUTPERFORM recommendation for TSLA on March 13, 2024 08:49AM ET. The previous analyst recommendation was Outperform.TSLA was trading at $177.54 at issue of the analyst...

March 13, 2024   TSLA 5.33%

Benchmark analyst issues BUY recommendation for NVDA on March 13, 2024 08:51AM ET. The previous analyst recommendation was Buy.NVDA was trading at $919.13 at issue of the analyst...

March 13, 2024   NVDA 0.25%

Barclays analyst issues EQUAL-WEIGHT recommendation for COST on March 11, 2024 08:16AM ET. The previous analyst recommendation was Equal-Weight.COST was trading at $725.56 at issue of the analyst...

March 11, 2024   COST 1.12%